PKC δ (C-20)

• Supplier: Santa Cruz Biotechnology
• Catalog: sc-937
• Prices: $279.00
• Sizes: 200 µg/ml
• Host: Rabbit
• Clonality: Polyclonal
• Isotype: rabbit IgG
• Applications: WB IP ICC/IF IHC-P ELISA
• Species Reactivities: Mouse, Rat, Human, Drosophila, Horse, Bovine
• Antigen: C-terminal (h)
• Description: Rabbit Polyclonal
• Gene: PRKCD

Product images

PKC δ (C-20)-G: sc-937-G. Western blot analysis of PKC δ expression in A-431 whole cell lysate.

PKC δ (C-20)-G: sc-937-G. Immunofluorescence staining of methanol-fixed A-431 cells showing cytoplasmic staining.

Western blot detection of PKC δ phosphorylation using untreated (A,C) and PMA-treated (B,D) HeLa cells. Blots were probed with p-PKC δ (Thr 507)-R: sc-11770-R (A,B) and PKC δ (C-20)-G: sc-937-G (C,D).

Western blot analysis of PKC δ expression in 3611-RF (A), A-431 (B), HeLa (C), Jurkat (D) and K-562 (E) whole cell lysates. Antibodies tested include PKC δ (C-17): sc-213 (A) and PKC δ (C-20): sc-937 (B-E).

PKC δ siRNA (h): sc-36253. Western blot analysis of PKC δ expression in non-transfected control (A) and PKC δ siRNA transfected (B) Jurkat cells. Blot probed with PKC δ (C-20): sc-937. GAPDH (FL-335): sc-25778 used as specificity and loading control.

PKC δ (C-20): sc-937. Immunoperoxidase staining of formalin fixed, paraffin-embedded human tonsil tissue showing cytoplasmic and membrane staining of lymphoid cells and squamous epithelial cells at low (A) and high (B) magnification. Kindly provided by The Swedish Human Protein Atlas (HPA) program.

PKC δ (C-20): sc-937. Western blot analysis of PKC δ expression in non-transfected 293T: sc-117752 (A), mouse PKC δ transfected 293T: sc-122605 (B) and NIH/3T3 (C) whole cell lysates.

PKC δ (C-20)-G: sc-937-G. Western blot analysis of PKC δ expression in non-transfected 293T: sc-117752 (A), mouse PKC δ transfected 293T: sc-122605 (B) and NIH/3T3 (C) whole cell lysates.

Western blot analysis of PKC phosphorylation in untreated (A,D), pervanadate treated (B,E) and pervanadate and lambda protein phosphatase (sc-200312A) treated (C,F) A-431 whole cell lysates. Antibodies tested include p-PKC (Tyr 155)-R: sc-18367-R (A,B,C) and PKC (C-20): sc-937 (D,E,F).

Western blot analysis of PKC phosphorylation in untreated (A,D), pervanadate treated (B,E) and pervanadate and lambda protein phosphatase (sc-200312A) treated (C,F) A-431 whole cell lysates. Antibodies tested include p-PKC (Tyr 332)-R: sc-18365-R (A,B,C) and PKC (C-20): sc-937 (D,E,F).

Western blot analysis of PKC phosphorylation in untreated (A,D), pervanadate treated (B,E) and pervanadate treated and lambda protein phosphatase (sc-200312A) treated (C,F) A-431 whole cell lysates. Antibodies tested include p-PKC (Tyr 52)-R: sc-18362-R (A,B,C) and PKC (C-20): sc-937 (D,E,F).

Western blot analysis of PKC βIl/δ phosphorylation in untreated (A,C) and lambda protein phosphatase treated (B,D) U-937 whole cell lysates. Antibodies tested include p-PKC βIl/δ (Ser 660)-R: sc-11760-R (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,D), PMA treated (B,E) and PMA and lambda protein phosphatase treated (C,F) HeLa whole cell lysates. Antibodies tested include p-PKC δ (Tyr 311)-R: sc-18364-R (A,B,C) and PKC δ (C-20): sc-937 (D,E,F).

Western blot analysis of PKC βIl/δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) U-937 whole cell lysates. Antibodies tested include p-PKC βIl/δ (Ser 660)-R: sc-11760-R (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC βIl/δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) HeLa whole cell lysates. Antibodies tested include p-PKC βIl/δ (E-7): sc-365463 (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC βIl/δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) U-937 whole cell lysates. Antibodies tested include p-PKC βIl/δ (E-7): sc-365463 (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) RAW 264.7 whole cell lysates. Antibodies tested include p-PKC δ (Thr 507)-R: sc-11770-R (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) RAW 264.7 whole cell lysates. Antibodies tested include p-PKC δ (F-7): sc-365969 (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) HeLa whole cell lysates. Antibodies tested include p-PKC δ (Ser 645)-R: sc-18369-R (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) RAW 264.7 whole cell lysates. Antibodies tested include p-PKC δ (Ser 645)-R: sc-18369-R (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,D), serum starved and serum treated (B,E) and serum starved, serum treated and lambda protein phosphatase (sc-200312A) treated (C,F) HeLa whole cell lysates. Antibodies tested include p-PKC δ (Tyr 565)-R: sc-18372-R (A,B,C) and PKC δ (C-20): sc-937 (D,E,F).

Western blot analysis of PKC δ phosphorylation in untreated (A,D), serum starved and serum treated (B,E) and serum starved, serum treated and lambda protein phosphatase (sc-200312A) treated (C,F) HeLa whole cell lysates. Antibodies tested include p-PKC δ (Tyr 155)-R: sc-23770-R (A,B,C) and PKC δ (C-20): sc-937 (D,E,F).

Western blot analysis of PKC δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) HeLa whole cell lysates. Antibodies tested include p-PKC δ (Ser 645)-R: sc-18369-R (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) RAW 264.7 whole cell lysates. Antibodies tested include p-PKC δ (Ser 645)-R: sc-18369-R (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) HeLa whole cell lysates. Antibodies tested include p-PKC δ (H-9): sc-374613 (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,C) and lambda protein phosphatase (sc-200312A) treated (B,D) RAW 264.7 whole cell lysates. Antibodies tested include p-PKC δ (H-9): sc-374613 (A,B) and PKC δ (C-20): sc-937 (C,D).

Western blot analysis of PKC δ phosphorylation in untreated (A,D), Ser/Thr induction cocktail (sc-362324) treated (B,E) and Ser/Thr induction cocktail (sc-362324) and lambda protein phosphatase (sc-200312A) treated (C,F) A-431 whole cell lysates. Antibodies tested include p-PKC δ (Tyr 311)-R: sc-18364-R (A,B,C) and PKC δ (C-20): sc-937 (D,E,F).

Western blot analysis of PKC δ phosphorylation in untreated (A,D), Ser/Thr induction cocktail (sc-362324) treated (B,E) and Ser/Thr induction cocktail (sc-362324) and lambda protein phosphatase (sc-200312A) treated (C,F) A-431 whole cell lysates. Antibodies tested include p-PKC δ (A-8): sc-377560 (A,B,C) and PKC δ (C-20): sc-937 (D,E,F).